Stock listing
KRX:007460 Aprogen, Inc (에이프로젠) 주가
Follow Aprogen, Inc into a list and get an email when it puts out news.
Share price · KRX:007460
₩1,616.00 KRW -104.00 (-6.0%)
Close on Nov 20, 2026
- Day range
- ₩1,552.00 – ₩1,698.00 KRWNov 20, 2026
- Volume
- 108,692 sharesNov 20, 2026
- Market cap
- ₩35.85B KRWAt the close on Nov 20, 2026 · price × 22.19M shares outstanding
- 52-week range
- ₩1,552.00 – ₩14,070.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩702.3M KRWMedian day 117,511 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:007460 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩1,616.00 | -104.00 | -6.0% | ₩1,698.00 | ₩1,698.00 | ₩1,552.00 | 108,692 | |
| ₩1,720.00 | -35.00 | -2.0% | ₩1,756.00 | ₩1,792.00 | ₩1,705.00 | 93,836 | |
| ₩1,755.00 | -58.00 | -3.2% | ₩1,847.00 | ₩1,847.00 | ₩1,665.00 | 59,667 | |
| ₩1,813.00 | -68.00 | -3.6% | ₩1,885.00 | ₩1,916.00 | ₩1,808.00 | 56,478 | |
| ₩1,881.00 | -4.00 | -0.2% | ₩1,863.00 | ₩1,924.00 | ₩1,863.00 | 36,069 | |
| ₩1,885.00 | -75.00 | -3.8% | ₩1,960.00 | ₩2,000.00 | ₩1,865.00 | 55,971 | |
| ₩1,960.00 | +82.00 | +4.4% | ₩1,894.00 | ₩2,050.00 | ₩1,894.00 | 117,397 | |
| ₩1,878.00 | +158.00 | +9.2% | ₩1,720.00 | ₩1,910.00 | ₩1,720.00 | 150,949 | |
| ₩1,720.00 | 0.00 | 0.0% | ₩1,780.00 | ₩1,780.00 | ₩1,700.00 | 41,536 | |
| ₩1,720.00 | -32.00 | -1.8% | ₩1,700.00 | ₩1,745.00 | ₩1,615.00 | 109,986 | |
| ₩1,752.00 | -74.00 | -4.1% | ₩1,808.00 | ₩1,829.00 | ₩1,739.00 | 78,542 | |
| ₩1,826.00 | +56.00 | +3.2% | ₩1,777.00 | ₩1,828.00 | ₩1,713.00 | 177,199 | |
| ₩1,770.00 | -61.00 | -3.3% | ₩1,802.00 | ₩1,887.00 | ₩1,723.00 | 86,745 | |
| ₩1,831.00 | -39.00 | -2.1% | ₩1,820.00 | ₩1,870.00 | ₩1,800.00 | 198,225 | |
| ₩1,870.00 | -27.00 | -1.4% | ₩1,878.00 | ₩1,921.00 | ₩1,810.00 | 131,029 | |
| ₩1,897.00 | -43.00 | -2.2% | ₩1,940.00 | ₩1,945.00 | ₩1,897.00 | 111,455 | |
| ₩1,940.00 | +26.00 | +1.4% | ₩1,914.00 | ₩1,987.00 | ₩1,911.00 | 373,975 | |
| ₩1,914.00 | -14.00 | -0.7% | ₩1,944.00 | ₩1,944.00 | ₩1,906.00 | 37,342 | |
| ₩1,928.00 | +28.00 | +1.5% | ₩1,896.00 | ₩1,937.00 | ₩1,890.00 | 49,872 | |
| ₩1,900.00 | -20.00 | -1.0% | ₩1,885.00 | ₩1,945.00 | ₩1,841.00 | 96,964 | |
| ₩1,920.00 | -30.00 | -1.5% | ₩1,960.00 | ₩1,960.00 | ₩1,910.00 | 49,345 | |
| ₩1,950.00 | -3.00 | -0.2% | ₩1,954.00 | ₩2,010.00 | ₩1,942.00 | 54,071 | |
| ₩1,953.00 | -41.00 | -2.1% | ₩1,980.00 | ₩2,030.00 | ₩1,923.00 | 67,336 | |
| ₩1,994.00 | +19.00 | +1.0% | ₩1,930.00 | ₩1,994.00 | ₩1,930.00 | 54,279 | |
| ₩1,975.00 | +62.00 | +3.2% | ₩1,913.00 | ₩1,989.00 | ₩1,902.00 | 74,548 | |
| ₩1,913.00 | -85.00 | -4.3% | ₩1,910.00 | ₩1,969.00 | ₩1,895.00 | 121,958 | |
| ₩1,998.00 | +53.00 | +2.7% | ₩1,927.00 | ₩2,060.00 | ₩1,927.00 | 107,700 | |
| ₩1,945.00 | -25.00 | -1.3% | ₩1,952.00 | ₩1,961.00 | ₩1,897.00 | 199,952 | |
| ₩1,970.00 | -105.00 | -5.1% | ₩2,050.00 | ₩2,130.00 | ₩1,970.00 | 126,993 | |
| ₩2,075.00 | -85.00 | -3.9% | ₩2,160.00 | ₩2,205.00 | ₩2,070.00 | 167,157 | |
| ₩2,160.00 | -15.00 | -0.7% | ₩2,175.00 | ₩2,335.00 | ₩2,155.00 | 617,191 | |
| ₩2,175.00 | +35.00 | +1.6% | ₩2,120.00 | ₩2,190.00 | ₩2,110.00 | 160,008 | |
| ₩2,140.00 | +164.00 | +8.3% | ₩1,976.00 | ₩2,195.00 | ₩1,976.00 | 362,977 | |
| ₩1,976.00 | +50.00 | +2.6% | ₩1,923.00 | ₩1,977.00 | ₩1,875.00 | 125,489 | |
| ₩1,926.00 | -30.00 | -1.5% | ₩1,952.00 | ₩2,000.00 | ₩1,926.00 | 105,116 | |
| ₩1,956.00 | -64.00 | -3.2% | ₩2,025.00 | ₩2,025.00 | ₩1,941.00 | 134,382 | |
| ₩2,020.00 | +10.00 | +0.5% | ₩2,010.00 | ₩2,110.00 | ₩2,005.00 | 143,350 | |
| ₩2,010.00 | -20.00 | -1.0% | ₩2,030.00 | ₩2,110.00 | ₩1,999.00 | 123,574 | |
| ₩2,030.00 | -10.00 | -0.5% | ₩2,045.00 | ₩2,095.00 | ₩2,000.00 | 90,867 | |
| ₩2,040.00 | +42.00 | +2.1% | ₩2,060.00 | ₩2,070.00 | ₩1,985.00 | 117,624 | |
| ₩1,998.00 | -7.00 | -0.3% | ₩1,999.00 | ₩2,050.00 | ₩1,997.00 | 98,342 | |
| ₩2,005.00 | +37.00 | +1.9% | ₩1,968.00 | ₩2,030.00 | ₩1,951.00 | 114,132 | |
| ₩1,968.00 | +6.00 | +0.3% | ₩1,990.00 | ₩1,997.00 | ₩1,948.00 | 103,206 | |
| ₩1,962.00 | -30.00 | -1.5% | ₩1,994.00 | ₩1,995.00 | ₩1,950.00 | 127,146 | |
| ₩1,992.00 | -38.00 | -1.9% | ₩2,015.00 | ₩2,065.00 | ₩1,981.00 | 110,232 | |
| ₩2,030.00 | +30.00 | +1.5% | ₩2,025.00 | ₩2,055.00 | ₩1,976.00 | 144,847 | |
| ₩2,000.00 | 0.00 | 0.0% | ₩2,000.00 | ₩2,035.00 | ₩1,980.00 | 100,910 | |
| ₩2,000.00 | -25.00 | -1.2% | ₩2,025.00 | ₩2,035.00 | ₩1,996.00 | 181,086 | |
| ₩2,025.00 | -95.00 | -4.5% | ₩2,125.00 | ₩2,130.00 | ₩2,025.00 | 267,972 | |
| ₩2,120.00 | -40.00 | -1.9% | ₩2,160.00 | ₩2,175.00 | ₩2,100.00 | 334,121 | |
| ₩2,160.00 | +80.00 | +3.8% | ₩2,470.00 | ₩2,630.00 | ₩2,155.00 | 2,889,048 | |
| ₩2,080.00 | +20.00 | +1.0% | ₩2,100.00 | ₩2,120.00 | ₩2,050.00 | 150,821 | |
| ₩2,060.00 | -100.00 | -4.6% | ₩2,135.00 | ₩2,135.00 | ₩2,055.00 | 212,600 | |
| ₩2,160.00 | -180.00 | -7.7% | ₩2,320.00 | ₩2,320.00 | ₩2,140.00 | 601,028 | |
| ₩2,340.00 | -50.00 | -2.1% | ₩2,390.00 | ₩2,390.00 | ₩2,260.00 | 196,423 | |
| ₩2,390.00 | +25.00 | +1.1% | ₩2,380.00 | ₩2,465.00 | ₩2,310.00 | 266,390 | |
| ₩2,365.00 | -335.00 | -12.4% | ₩2,620.00 | ₩2,625.00 | ₩2,332.00 | 966,257 | |
| ₩2,700.00 | +200.00 | +8.0% | ₩2,565.00 | ₩3,250.00 | ₩2,510.00 | 6,249,101 | |
| ₩2,500.00 | +195.00 | +8.5% | ₩2,305.00 | ₩2,760.00 | ₩2,240.00 | 392,717 | |
| ₩2,305.00 | +25.00 | +1.1% | ₩2,305.00 | ₩2,375.00 | ₩2,255.00 | 97,313 | |
| ₩2,280.00 | -65.00 | -2.8% | ₩2,345.00 | ₩2,400.00 | ₩2,230.00 | 92,133 | |
| ₩2,345.00 | -35.00 | -1.5% | ₩2,410.00 | ₩2,540.00 | ₩2,335.00 | 92,003 |
Splits
7 splits since 2001 · KRX:007460 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-15 | Consolidation | |
| 1-for-3 | Consolidation | |
| 1-for-5 | Consolidation | |
| 1.2634-for-1 | Split | |
| 85-for-76 | Split | |
| 1.0551-for-1 | Split | |
| 10-for-1 | Split |
- Ticker
- KRX:007460
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Aprogen, Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
Valuation
EV/sales 0.2× against a median of 175×: 2nd lowest of 3 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩28.69B KRW
- P/E
- Loss
- EV/sales
- 0.2×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.6×
- Gross margin
- 26.6%
- Operating margin
- −66.4%
- Net margin
- −60.1%
- Debt to equity
- 0.6×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Aprogen, Inc · KRX:007460 | US$26.64M | US$21.31M | n/a | 0.2× | n/a | 0.6× | −60.1% | 0.6× | n/a |
| Holy Stone Healthcare Co., Ltd. · TPEX:4194 | US$27.49M | US$25.08M | n/a | n/a | n/a | 7.3× | n/a | 0.0× | n/a |
| SoftOx Solutions AS · OSL:SOFTX | US$27.28M | US$25.25M | n/a | n/a | n/a | 11.6× | n/a | 0.0× | n/a |
| Edesa Biotech, Inc. · NASDAQ:EDSA | US$27.02M | US$16.72M | n/a | n/a | n/a | 3.1× | n/a | 0.0× | 0.47 |
| Amplia Therapeutics Ltd. · ASX:ATX | US$26.84M | US$8.63M | n/a | n/a | n/a | 1.0× | n/a | 0.0× | n/a |
| Nasus Pharma Ltd. · AMEX:NSRX | US$26.82M | US$15.11M | n/a | n/a | n/a | 2.4× | n/a | 0.0× | 0.99 |
| Telomir Pharmaceuticals, Inc. · NASDAQ:TELO | US$26.82M | US$22.30M | n/a | n/a | n/a | 6.1× | n/a | 0.0× | 1.74 |
| BriaCell Therapeutics Corp · TSX:BCT | US$26.79M | US$6.25M | n/a | n/a | n/a | 1.7× | n/a | 0.0× | 1.07 |
| Alterity Therapeutics Ltd. · ASX:ATH | US$26.76M | US$2.18M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | n/a |
| EyePoint, Inc. · NASDAQ:EYPT | US$26.65M | −US$72.44M | n/a | −28.1× | n/a | 0.3× | n/a | 0.2× | 1.36 |
| PolTREG Spolka Akcyjna · GPW:PTG | US$26.09M | US$22.35M | n/a | 378× | n/a | 2.2× | n/a | 0.1× | n/a |
| Median of the others | US$26.82M | US$15.92M | 175× | 2.3× | 0.0× | 1.07 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2025 | Apr 7, 2025 | −4.9% |
| Q3 2024 | Nov 13, 2024 | −0.9% |
| Q2 2024 | Aug 14, 2024 | −0.3% |
| Q1 2024 | May 14, 2024 | −0.8% |
| Q3 2023 | Nov 15, 2023 | +0.8% |
| Q2 2023 | Aug 15, 2023 | −1.4% |
| Q1 2023 | May 15, 2023 | +0.9% |
| Q4 2022 | Mar 27, 2023 | −3.6% |
| Q3 2022 | Nov 14, 2022 | −28.4% |
| Q2 2022 | Aug 12, 2022 | +2.7% |
All 14 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2022 | May 17, 2022 | 0.0% |
| Q3 2021 | Nov 18, 2021 | +1.5% |
| Quarter to Jun 30, 2021 | Aug 17, 2021 | −2.7% |
| Quarter to Mar 31, 2021 | May 17, 2021 | −3.5% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 118.0B | 150.1B | 150.6B | 78.3B | 141.2B | 127.1B | 78.2B | 51.0B | 44.9B | 54.8B |
| Cost of revenue | 84.7B | 115.2B | 114.8B | 72.2B | 110.0B | 92.7B | 58.9B | 41.9B | 40.6B | 44.9B |
| Gross profit | 33.2B | 34.9B | 35.8B | 6.15B | 31.3B | 34.5B | 19.4B | 9.18B | 4.30B | 9.94B |
| Research and development | 51.7B | 56.8B | 42.8B | 38.6B | 1.98B | 1.03B | 1.87B | 4.38B | 407.0M | 359.8M |
| Selling, general and administrative | 35.0B | 29.0B | 40.9B | 41.0B | 15.7B | 12.1B | 6.83B | 621.0M | 349.7M | 322.3M |
| Operating income | -95.6B | -86.8B | -88.9B | -114.4B | -2.67B | 3.97B | 2.57B | 1.57B | 1.83B | 5.06B |
| Depreciation and amortization | 23.6B | 24.3B | 29.1B | 28.4B | 25.3B | 4.31B | 3.25B | 2.03B | 2.23B | 2.34B |
| EBITDA | -72.0B | -62.5B | -59.8B | -86.0B | 22.6B | 8.28B | 5.82B | 3.61B | 4.06B | 7.40B |
| Interest expense | 4.76B | 1.01B | 631.8M | 9.91B | 11.4B | 5.23B | 9.15B | 20.7B | 0 | 0 |
| Income before tax | -142.3B | -98.7B | -95.2B | -115.6B | -9.18B | -39.1B | 16.9B | -22.0B | 1.16B | 3.32B |
| Income tax | 473.8M | -111.7M | -6.45B | -1.40B | 2.91B | -1.18B | ||||
| Net income | -70.2B | -58.1B | -55.6B | -98.7B | -18.0B | -46.5B | 11.7B | -32.1B | 2.34B | 2.41B |
| Earnings per share, basic | -3,411.19 | -3,072.90 | -227.87 | -423.56 | -90.39 | -254.12 | 76.19 | -349.38 | 47.03 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 45.1B | 37.2B | 35.7B | 43.1B | 62.4B | 96.6B | 71.7B | 59.9B | 112.1B | 442.3M |
| Short-term investments | 5.61B | 6.50B | 5.00B | 4.39B | 97.4B | 140.8B | 208.3B | 59.8B | 85.7B | 1.12B |
| Receivables | 26.0B | 19.7B | 24.8B | 21.4B | 1.57B | 20.3B | 134.0B | 19.0B | 11.7B | 17.8B |
| Inventory | 60.9B | 62.5B | 60.8B | 61.5B | 23.3B | 17.3B | 17.4B | 5.18B | 4.40B | 4.11B |
| Current assets | 178.6B | 134.3B | 144.2B | 211.6B | 103.1B | 434.5B | 329.2B | 135.9B | 214.9B | 24.2B |
| Property, plant and equipment | 365.1B | 314.5B | 40.2B | 66.4B | 33.5B | 43.5B | ||||
| Goodwill | 51.0B | 0 | 0 | 0 | 23.1M | 9.62M | 9.62M | 9.62M | 516.6M | |
| Total assets | 717.3B | 610.0B | 594.4B | 599.9B | 824.1B | 834.4B | 654.4B | 395.2B | 267.0B | 78.6B |
| Accounts payable | 5.25B | 3.42B | 2.73B | 4.19B | 3.92B | 1.42B | 1.45B | 888.9M | 1.50B | 1.79B |
| Current liabilities | 183.8B | 113.0B | 125.6B | 89.9B | 421.9B | 85.1B | 108.7B | 99.8B | 54.9B | 42.7B |
| Long-term debt | 40.0B | 32.0B | 32.0B | 31.3B | 31.0B | 26.3B | 7.60B | 92.6B | 50.2B | 333.3M |
| Total liabilities | 258.7B | 169.9B | 176.7B | 138.9B | 119.7B | 144.3B | 127.5B | 199.6B | 117.4B | 43.3B |
| Shareholders' equity | 158.3B | 158.6B | 147.8B | 215.1B | 336.0B | 319.1B | 303.3B | 195.5B | 149.6B | 35.3B |
| Shares outstanding | 20.6M | 18.9M | 244.1M | 232.9M | 199.2M | 182.9M | 153.7M | 91.9M | 49.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -32.7B | -45.0B | -58.2B | -113.5B | -84.7B | 22.5B | -1.12B | -1.49B | 8.07B | 2.73B |
| Capital spending | -32.2B | -23.1B | -54.9B | -19.6B | -34.4B | -2.58B | -7.85B | -4.04B | -78.3M | -1.33B |
| Free cash flow | -64.9B | -68.1B | -113.0B | -138.3B | -10.7B | 19.4B | -9.29B | -5.53B | 8.00B | 1.40B |
| Cash from investing | 70.2B | -12.8B | -168.5B | -151.4B | -210.0B | -84.4B | ||||
| Cash from financing | 70.8B | 110.4B | 171.0B | 164.2B | 159.3B | 188.0B | ||||
| Dividends paid | -84.6K | |||||||||
| Share buybacks | -97.8K | -15.8B | 63.7B | |||||||
| Change in cash | 7.99B | 1.48B | -7.39B | 27.2B | 12.9B | 24.9B | 11.7B | -52.2B | 111.7B | -895.6M |
Cap table
Built by 6ix from Aprogen, Inc’s releases
- Common shares
- 22,185,944
- Fully diluted
- 22,185,944
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 22,185,944 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 22,185,944 |
Log in to ask 6ix AI your own questions about Aprogen, Inc.